A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
A randomized, double-blind, placebo-controlled multicenter study evaluating the safety and efficacy of Rituximab (Mabthera®) in patients with new onset generalized myasthenia gravis (MG).
Epistemonikos ID: 11fb601f9348f1e75fe87328de097cd95d818597
First added on: May 17, 2024